The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.

Tirzepatide, a once-weekly injection to treat diabetes and obesity, is no longer in shortage, the FDA announced, potentially signaling a crackdown on copycat drugs in early 2025.MarsBars/Getty Images… [+4859 chars]

The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.

The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.

The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.

The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.
The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute